EP3934649 - METHODS OF TREATING DISEASE WITH LEVOKETOCONAZOLE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 22.03.2024 Database last updated on 15.06.2024 | |
Former | Request for examination was made Status updated on 10.12.2021 | ||
Former | The international publication has been made Status updated on 11.09.2020 | Most recent event Tooltip | 17.04.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Strongbridge Dublin Limited 900 Northbrook Drive, Suite 200 Trevose, Pennsylvania 19053 / US | [2022/02] | Inventor(s) | 01 /
COHEN, Fredric 900 Northbrook Drive Suite 200 Trevose, Pennsylvania 19053 / US | [N/P] |
Former [2022/02] | 01 /
COHEN, Fredric Trevose, Pennsylvania 19053 / US | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
Former [2022/02] | Gibson, Mark Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | Application number, filing date | 20766266.9 | 02.03.2020 | [2022/02] | WO2020US20644 | Priority number, date | US201962813399P | 04.03.2019 Original published format: US 201962813399 P | [2022/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020180784 | Date: | 10.09.2020 | Language: | EN | [2020/37] | Type: | A1 Application with search report | No.: | EP3934649 | Date: | 12.01.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.09.2020 takes the place of the publication of the European patent application. | [2022/02] | Search report(s) | International search report - published on: | US | 10.09.2020 | (Supplementary) European search report - dispatched on: | EP | 20.10.2022 | Classification | IPC: | A61K31/496, A61K31/155, A61P5/46, A61P43/00, A61K45/06 | [2022/47] | CPC: |
A61K45/06 (EP,IL,KR);
A61K31/497 (IL,US);
A61K31/496 (EP,IL,KR);
A61K31/155 (EP,IL,KR,US);
A61P43/00 (EP);
A61P5/38 (KR);
| C-Set: |
A61K31/155, A61K2300/00 (EP);
A61K31/496, A61K2300/00 (EP) |
Former IPC [2022/02] | A61K31/496, A61K31/155 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/02] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON KRANKHEITEN MIT LEVOKETOCONAZOL | [2022/02] | English: | METHODS OF TREATING DISEASE WITH LEVOKETOCONAZOLE | [2022/02] | French: | PROCÉDÉS DE TRAITEMENT D'UNE MALADIE AVEC DU LÉVOKÉTOCONAZOLE | [2022/02] | Entry into regional phase | 23.09.2021 | National basic fee paid | 23.09.2021 | Search fee paid | 23.09.2021 | Designation fee(s) paid | 23.09.2021 | Examination fee paid | Examination procedure | 23.09.2021 | Examination requested [2022/02] | 28.04.2023 | Amendment by applicant (claims and/or description) | 20.03.2024 | Invitation to indicate the basis for amendments (Time limit: M01) | 16.04.2024 | Reply to an invitation to indicate the basis for amendments | Fees paid | Renewal fee | 11.03.2022 | Renewal fee patent year 03 | 23.03.2023 | Renewal fee patent year 04 | 27.03.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2016048984 (CORTENDO AB PUBL [US]) [I] 1-15 * claims 1-29 * * abstract * * the whole document *; | [T] - FLESERIU MARIA ET AL, "Levoketoconazole: a novel treatment for endogenous Cushing's syndrome", EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, GB, (20210628), vol. 16, no. 4, doi:10.1080/17446651.2021.1945440, ISSN 1744-6651, pages 159 - 174, XP055969224 [T] 1-15 * page 162, column r, paragraph 2 * * the whole document * DOI: http://dx.doi.org/10.1080/17446651.2021.1945440 | International search | [A]US2018153883 (MARIN PER [SE]) [A] 1, 3, 10/1, 10/3, 11/10/1, 11/10/3, 14/3, 15/14/3, 16/14/3, 17/3 * ; entire document *; | [Y]WO2018106907 (NOVATARG INC [US]) [Y] 1, 3, 10/1, 10/3, 11/10/1, 11/10/3, 14/3, 15/14/3, 16/14/3, 17/3 * ; paragraphs [0017], [0029], [0133], [0321] *; | [Y]US2018338971 (KOZIOL THEODORE RICHARD [US]) [Y] 11/10/1, 11/10/3 * ; abstract; paragraph [0008] *; | [Y] - ROSSI, K et al., "Phase 3 Trial of Endogenous Cushing's Syndrome Treatment Meets Primary Endpoint", (20180813), pages 1 - 2, URL: https://www.mdmag.com/medical-news/phase-3-trial-endogenous-cushings-syndrome-treatment-meets-primary-endpoint, XP055735587 [Y] 1, 3, 10/1, 10/3, 11/10/1, 11/10/3, 14/3, 15/14/3, 16/14/3, 17/3 * ; first page, first, fourth and last paragraphs * | [PX] - FLESERIU, M et al., "Results From the Phase 3 Multicenter SONICS Study of Levoketoconazole: Subgroup Analysis of Cushing's Syndrome Patients With Diabetes Mellitus", Endocrine Society Annual Meeting, (20190326), XP055847542 [PX] 1, 3, 10/1, 10/3 |